These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4402637)

  • 1. Observations on the metabolism of cyclophosphamide.
    Connors TA; Foster AB; Gilsenan AM; Jarman M; Tisdale MJ
    Biochem Pharmacol; 1972 May; 21(9):1373-6. PubMed ID: 4402637
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of cyclophosphamide.
    Brock N; Hohorst HJ
    Cancer; 1967 May; 20(5):900-4. PubMed ID: 6024299
    [No Abstract]   [Full Text] [Related]  

  • 3. Modification of the alkylating ability of cyclophosphamide by fresh plasma.
    Hill BT; Harrap KR
    Chem Biol Interact; 1972 Jul; 5(2):117-25. PubMed ID: 5064934
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclophosphamide (endoxan) metabolism in the rabbit: metabolic balance and elimination kinetics in different tissues and organs following oral administration.
    Bories GF; Renerre MP; Rougeot JC
    J Anim Sci; 1973 May; 36(5):931-5. PubMed ID: 4703722
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic efficacy of cyclophosphamide as a function of its metabolism.
    Sladek NE
    Cancer Res; 1972 Mar; 32(3):535-42. PubMed ID: 5061308
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug metabolism in tumor-bearing rats. I. Activities of NADPH-linked electron transport and drug-metabolizing enzyme systems in liver microsomes of tumor-bearing rats.
    Kato R; Takanaka A; Takahashi A; Onoda K
    Jpn J Pharmacol; 1968 Jun; 18(2):224-44. PubMed ID: 4387084
    [No Abstract]   [Full Text] [Related]  

  • 7. In-vitro testing of cyclophosphamide on tumors.
    Kaufmann M; Mattern J; Volm M; Hohorst HJ; Peter G; Vollcker G
    Naturwissenschaften; 1975 Sep; 62(9):446-7. PubMed ID: 1186909
    [No Abstract]   [Full Text] [Related]  

  • 8. Different sensitivity of two Walker 256 carcinoma lines to cyclophosphamide: correlation with drug distribution, biotransformation and macromolecule binding.
    Donelli MG; Guaitani A; Torti L; Damia G; Corti F; Bianchi M; Tortoreto M; Pantarotto C; Bartosek I
    Oncology; 1986; 43(4):257-63. PubMed ID: 3725287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of induced tumour-resistance to cyclophosphamide by the in vitro short term test.
    Volm M; Mattern J; Wayss K
    Arch Gynakol; 1977 Nov; 223(4):249-57. PubMed ID: 579579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsomal activation of cyclophosphamide in vivo.
    Connors TA; Grover PL; McLoughlin AM
    Biochem Pharmacol; 1970 Apr; 19(4):1533-5. PubMed ID: 4398015
    [No Abstract]   [Full Text] [Related]  

  • 11. A simple, small scale cytotoxicity test, and its uses in drug metabolism studies.
    Phillips BJ
    Biochem Pharmacol; 1974 Jan; 23(1):131-8. PubMed ID: 4811054
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel metabolic products of cyclophosphamide in human urine.
    Cox PJ; Levin L
    Biochem Pharmacol; 1975 Jun; 24(11-12):1233-5. PubMed ID: 1169947
    [No Abstract]   [Full Text] [Related]  

  • 13. Differences of cyclophosphamide and 6-mercaptopurine metabolic rates in perfused liver of normal and tumour-bearing animals.
    Bartosek I; Donelli MG; Guaitani A; Colombo T; Russo R; Garattini S
    Biochem Pharmacol; 1975 Jan; 24(2):289-90. PubMed ID: 1111539
    [No Abstract]   [Full Text] [Related]  

  • 14. Formation of 4-ketocyclophosphamide by the oxidation of cyclophosphamide with KMnO4.
    Jarman M
    Experientia; 1973; 29(7):812-4. PubMed ID: 4724708
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of irradiation on the uptake of P32 by ascites and solid tumour cells and by their cellular components].
    Dragoni G; Damascelli B; Roncoroni L
    Minerva Radiol; 1966; 11(7):423-8. PubMed ID: 4292633
    [No Abstract]   [Full Text] [Related]  

  • 16. Activities of NADPH-linked electron transport system in tumor-bearing rats.
    Kato R; Takanaka A; Takahashi A
    Gan; 1968 Feb; 59(1):83-4. PubMed ID: 4385829
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies with cancer seeking isotopes.
    Nathanson L
    Mater Med Pol; 1971; 3(3):21-7. PubMed ID: 5162164
    [No Abstract]   [Full Text] [Related]  

  • 18. Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide.
    Connors TA; Cox PJ; Farmer PB; Foster AB; Jarman M
    Biochem Pharmacol; 1974 Jan; 23(1):115-29. PubMed ID: 4811053
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the effect of heparinoid on the distribution of 3 H- and 32 P-labelled cyclophosphamide in the organs of rats with a 3,4-benzopyrene sarcoma].
    Fahr K; Lorenz WJ; Scheer KE
    Nucl Med (Stuttg); 1970 Sep; 9(3):285-93. PubMed ID: 4107248
    [No Abstract]   [Full Text] [Related]  

  • 20. Alkylating agents.
    Connors TA
    Top Curr Chem; 1974; 52():141-71. PubMed ID: 4617337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.